APA

Gottfried M., Bennouna J., Bondarenko I., Douillard J., Heigener D. F., Krzakowski M., Mellemgaard A., Novello S., Orlov S., Summers Y., von Pawel J., Stöhr J., Kaiser R. & Reck M. (20180504). Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study. : Targeted oncology.

Chicago

Gottfried Maya, Bennouna Jaafar, Bondarenko Igor, Douillard Jean-Yves, Heigener David F, Krzakowski Maciej, Mellemgaard Anders, Novello Silvia, Orlov Sergei, Summers Yvonne, von Pawel Joachim, Stöhr Julia, Kaiser Rolf and Reck Martin. 20180504. Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study. : Targeted oncology.

Harvard

Gottfried M., Bennouna J., Bondarenko I., Douillard J., Heigener D. F., Krzakowski M., Mellemgaard A., Novello S., Orlov S., Summers Y., von Pawel J., Stöhr J., Kaiser R. and Reck M. (20180504). Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study. : Targeted oncology.

MLA

Gottfried Maya, Bennouna Jaafar, Bondarenko Igor, Douillard Jean-Yves, Heigener David F, Krzakowski Maciej, Mellemgaard Anders, Novello Silvia, Orlov Sergei, Summers Yvonne, von Pawel Joachim, Stöhr Julia, Kaiser Rolf and Reck Martin. Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study. : Targeted oncology. 20180504.